bioMérieux, a world leader in the field of in vitro diagnostics, is building upon its Full Microbiology Lab Automation™ (FMLA) concept by offering a new tool to its customers, LeanSigma® - today’s most recognized process and flow improvement methodology.
Winner conducting research on major cause of healthcare-associated infections
High-tech Mobile Laboratory on Cross Country Tour Highlighting Solutions for Laboratory Automation
Sepsis progresses so quickly yet there are few clues to indicate treatment is effective.
Company to Redirect Funding to Drive New Educational Programs and Customer Incentives.
bioMérieux, a global leader in the field of in vitro diagnostics, released its quarterly business review through March 31, 2009.
The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met on Friday, March 13 to approve the consolidated financial statements for the year ended December 31, 2008. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors.
bioMérieux participating in the AOAC Emergency Response Validation for peanut butter contamination testing. The AOAC Research Institute (RI), a subsidiary of AOAC INTERNATIONAL, granted Performance Tested MethodsSM certification to bioMérieux, a world leader in the field of in vitro diagnostics, for VIDAS® Easy SLM (Salmonella).
bioMérieux, a global leader in the field of in vitro diagnostics, released its business review for fourth-quarter and full-year 2008.
bioMérieux, a world leader in the field of in vitro diagnostics, is enhancing its TEMPO® line for food quality with the launch of one of the most rapid automated solutions for direct enumeration of yeast and mold. TEMPO YM delivers final results in half the time versus most other methods, including the ISO reference method (ISO 21527).
